British Patient CapitalFeaturedfundingGrey Wolf Therapeuticshealth techHÍREKInvestment NewsoxfordOxford Science EnterprisesPfizer VenturesVILÁG ANGOLPfizer Ventures co-leads £40m funding in Grey Wolf TherapeuticsMOCOHUJanuary 30, 2023 by MOCOHUJanuary 30, 20230 The corporate venture capital arm of Covid-19 vaccine maker Pfizer has co-led a $49m (£39.6m) investment into Oxford-based biotech startup Grey Wolf, which develops immuno-oncology...